Anorexia
65
1
4
35
Key Insights
Highlights
Success Rate
85% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
9.2%
6 terminated out of 65 trials
85.4%
-1.1% vs benchmark
22%
14 trials in Phase 3/4
17%
6 of 35 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 35 completed trials
Clinical Trials (65)
Nanocrystalline Megestrol Acetate Versus Placebo for Anorexia in Patients With Unresectable Hepatocellular Carcinoma Receiving TACE Combined With Targeted and Immunotherapy
Anamorelin Hydrochloride in Reducing Anorexia in Patients With Advanced Non-small Cell Lung Cancer
Olanzapine Versus Megestrol Acetate for the Treatment of Loss of Appetite Among Advanced Cancer Patients
Effects of Mirtazapine on Appetite in Advanced Cancer Patients
The Effect of a Protective Oral Care Protocol Using Peppermint Oil Mouthwash
Fecal Microbiota Transplant for Anorexia Nervosa
Effectiveness of Bacillus Spore Probiotics in Reducing Constipation, Anorexia, and Slow Weight Gain in Children
Olanzapine Anorexia Cachexia
Olanzapine for Cancer Related Anorexia-cachexia Syndrome
Study to Compare the Effects of Repeated Doses of an Investigational New Drug and a Placebo on Appetite in Advanced Cancer and Anorexia
Insights Into Participating in Clinical Studies for Anorexia
Adaptive Treatment for Adolescent Anorexia Nervosa
Comparison Between Mirtazapine and Megestrol for the Control of Anorexia-cachexia in Cancer Patients in Palliative Care.
Effect of Mirtazapine Versus Placebo in Patients With Non-small Cell Lung Cancer and Anorexia
Positive Affect Treatment (PAT) to Target Reward Mechanisms in Anorexia Nervosa
Outpatient Treatment of Severe and Enduring Anorexia Nervosa
Effect of a Symptom Diary on Symptom Care and Symptom Burden in Patients Treated With Chemotherapy: a Before-and-after-study
Comparing Real-time fMRI Neurofeedback Versus Sham for Altering Limbic and Eating Disturbances in Anorexia Nervosa
Study at the Man of the Profile of Chimiokines in the Anorexia Bound to the Cancerous Cachexy
Sativex® and Gentamicin for Optimized Pharmagological Treatment in Older Patients (CanPan)